Abbott Laboratories at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 05:00PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome. I'm Robbie Marcus, med tech analyst at JPMorgan. Really happy to introduce our next session with Abbott Labs and the CEO, Robert Ford. Robert, thanks for joining.

Robert B. Ford - Abbott Laboratories - Chairman of the Board, President & CEO

Thanks for having us.

Questions and Answers:

Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

So I want to start out, 2022 was an interesting year for everyone. Turning the calendar page, we're now in 2023. I thought it would be good to start off with how you see the world, the outlook for Abbott this year.

Robert B. Ford - Abbott Laboratories - Chairman of the Board, President & CEO

Sure. I mean I think you change from one month to the other, one day to the other, it doesn't all go away. I'd say -- I'm not going to give any kind of specific guidance for Abbott today. We'll do that in a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot